MJN develops the mjn-SERAS device, which utilizes real-time monitoring technology to predict epileptic seizures by sending alerts to users and their trusted contacts when seizure risk is elevated. This solution aims to significantly enhance the quality of life for individuals with epilepsy by providing timely warnings that can help prevent injury and improve safety.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with epilepsy face the risk of unpredictable seizures, which can lead to injury and reduced quality of life. Current methods for predicting seizures are often unreliable or require constant monitoring in a clinical setting.
Solution
MJN develops mjn-SERAS, a real-time monitoring system designed to predict epileptic seizures and improve the quality of life for individuals with epilepsy. The system uses a wearable device to monitor physiological signals and sends alerts to the user and their trusted contacts when the risk of a seizure is elevated. By providing timely warnings, mjn-SERAS aims to help prevent injuries and improve safety, allowing users to take precautions and avoid potentially dangerous situations. The device is a CE-marked medical device, adhering to European standards for safety and efficacy.
Target Audience
The primary users are individuals diagnosed with epilepsy and their caregivers, seeking a reliable and proactive seizure prediction system.
Features
- Real-time monitoring of physiological signals to detect pre-seizure patterns
- Predictive algorithm that calculates the risk of an imminent seizure
- Mobile app (Android only) that displays the seizure risk level and sends alerts
- Customizable alert settings to notify users and contacts at different risk levels
- Data logging and analysis to track seizure patterns over time
- Wireless connectivity for seamless data transfer and software updates
- CE marking, ensuring compliance with European medical device standards